2022 Ryan White HIV/AIDS Program CLINICAL CONFERENCE Evaluation: Monday, October 17, 2022

DAY 2: MONDAY, OCTOBER 17, 2022

Question Title

* 1. Please indicate your academic degree, license, or position. (Select all that apply.)

PharmD/RPh

PhD

Other (please specify)

2. Please rate each presentation that you attended. If you did not attend or the question is not applicable, leave it blank or choose "N/A," respectively.

Question Title

* LECTURE: mRNA Vaccine Development for HIV Vaccines
Richard A. Koup, MD

	Excellent	Very Good	Good	Fair	Poor	N/A
Content	Content Excellent	Content Very Good	Content Good	Content Fair	Content Poor	Content N/A
Effectiveness of speaker's teaching methods	Effectiveness of speaker's teaching methods Excellent	Effectiveness of speaker's teaching methods Very Good	Effectiveness of speaker's teaching methods Good	Effectiveness of speaker's teaching methods Fair	Effectiveness of speaker's teaching methods Poor	Effectiveness of speaker's teaching methods N/A
Value in fulfilling objectives for this presentation	Value in fulfilling objectives for this presentation Excellent	Value in fulfilling objectives for this presentation Very Good	Value in fulfilling objectives for this presentation Good	Value in fulfilling objectives for this presentation Fair	Value in fulfilling objectives for this presentation Poor	Value in fulfilling objectives for this presentation N/A
Value to your practice/responsibility	Value to your practice/responsibility Excellent	Value to your practice/responsibility Very Good	Value to your practice/responsibility Good	Value to your practice/responsibility Fair	Value to your practice/responsibility Poor	Value to your practice/responsibility N/A
Freedom from commercial bias or influence	Freedom from commercial bias or influence Excellent	Freedom from commercial bias or influence Very Good	Freedom from commercial bias or influence Good	Freedom from commercial bias or influence Fair	Freedom from commercial bias or influence Poor	Freedom from commercial bias or influence N/A

Please comment:

Question Title

* LECTURE: New and Investigational Antiretroviral Drugs
Constance A. Benson, MD

	Excellent	Very Good	Good	Fair	Poor	N/A
Content	Content Excellent	Content Very Good	Content Good	Content Fair	Content Poor	Content N/A
Effectiveness of speaker's teaching methods	Effectiveness of speaker's teaching methods Excellent	Effectiveness of speaker's teaching methods Very Good	Effectiveness of speaker's teaching methods Good	Effectiveness of speaker's teaching methods Fair	Effectiveness of speaker's teaching methods Poor	Effectiveness of speaker's teaching methods N/A
Value in fulfilling objectives for this presentation	Value in fulfilling objectives for this presentation Excellent	Value in fulfilling objectives for this presentation Very Good	Value in fulfilling objectives for this presentation Good	Value in fulfilling objectives for this presentation Fair	Value in fulfilling objectives for this presentation Poor	Value in fulfilling objectives for this presentation N/A
Value to your practice/responsibility	Value to your practice/responsibility Excellent	Value to your practice/responsibility Very Good	Value to your practice/responsibility Good	Value to your practice/responsibility Fair	Value to your practice/responsibility Poor	Value to your practice/responsibility N/A
Freedom from commercial bias or influence	Freedom from commercial bias or influence Excellent	Freedom from commercial bias or influence Very Good	Freedom from commercial bias or influence Good	Freedom from commercial bias or influence Fair	Freedom from commercial bias or influence Poor	Freedom from commercial bias or influence N/A

Please comment:

Question Title

* CASES: Antiretroviral Therapy Cases from the Clinic(ians)
Michael S. Saag, MD

	Excellent	Very Good	Good	Fair	Poor	N/A
Content	Content Excellent	Content Very Good	Content Good	Content Fair	Content Poor	Content N/A
Effectiveness of speaker's teaching methods	Effectiveness of speaker's teaching methods Excellent	Effectiveness of speaker's teaching methods Very Good	Effectiveness of speaker's teaching methods Good	Effectiveness of speaker's teaching methods Fair	Effectiveness of speaker's teaching methods Poor	Effectiveness of speaker's teaching methods N/A
Value in fulfilling objectives for this presentation	Value in fulfilling objectives for this presentation Excellent	Value in fulfilling objectives for this presentation Very Good	Value in fulfilling objectives for this presentation Good	Value in fulfilling objectives for this presentation Fair	Value in fulfilling objectives for this presentation Poor	Value in fulfilling objectives for this presentation N/A
Value to your practice/responsibility	Value to your practice/responsibility Excellent	Value to your practice/responsibility Very Good	Value to your practice/responsibility Good	Value to your practice/responsibility Fair	Value to your practice/responsibility Poor	Value to your practice/responsibility N/A
Freedom from commercial bias or influence	Freedom from commercial bias or influence Excellent	Freedom from commercial bias or influence Very Good	Freedom from commercial bias or influence Good	Freedom from commercial bias or influence Fair	Freedom from commercial bias or influence Poor	Freedom from commercial bias or influence N/A

Please comment:

Question Title

* Panelists and Discussion: Antiretroviral Therapy Cases from the Clinic(ians)

	Excellent	Very Good	Good	Fair	Poor	N/A
Effectiveness of panel format	Effectiveness of panel format Excellent	Effectiveness of panel format Very Good	Effectiveness of panel format Good	Effectiveness of panel format Fair	Effectiveness of panel format Poor	Effectiveness of panel format N/A
Value of panel member's contributions to the discussion	Value of panel member's contributions to the discussion Excellent	Value of panel member's contributions to the discussion Very Good	Value of panel member's contributions to the discussion Good	Value of panel member's contributions to the discussion Fair	Value of panel member's contributions to the discussion Poor	Value of panel member's contributions to the discussion N/A
Freedom from commercial bias	Freedom from commercial bias Excellent	Freedom from commercial bias Very Good	Freedom from commercial bias Good	Freedom from commercial bias Fair	Freedom from commercial bias Poor	Freedom from commercial bias N/A

Please comment:

Question Title

* 1. Please indicate your academic degree, license, or position. (Select all that apply.)

Question Title

* LECTURE: mRNA Vaccine Development for HIV VaccinesRichard A. Koup, MD

Question Title

* LECTURE: New and Investigational Antiretroviral DrugsConstance A. Benson, MD

Question Title

* CASES: Antiretroviral Therapy Cases from the Clinic(ians)Michael S. Saag, MD

Question Title

* Panelists and Discussion: Antiretroviral Therapy Cases from the Clinic(ians)

* LECTURE: mRNA Vaccine Development for HIV Vaccines
Richard A. Koup, MD

* LECTURE: New and Investigational Antiretroviral Drugs
Constance A. Benson, MD

* CASES: Antiretroviral Therapy Cases from the Clinic(ians)
Michael S. Saag, MD